Literature DB >> 8757181

What is the role of thymidine phosphorylase in tumor angiogenesis.

J Folkman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8757181     DOI： 10.1093/jnci/88.16.1091

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  14 in total

1.  Transfection of thymidine phosphorylase cDNA to human hepatocellular carcinoma cells enhances sensitivity to fluoropyrimidine but augments endothelial cell migration.

Authors:  Jian Zhou; Yong-Sheng Xiao; Zhao-You Tang; Jia Fan; Zhi-Quan Wu; Yan Zhao; Qiong Xue; Zao-Zhuo Shen; Yin-Kun Liu; Sheng-Long Ye
Journal:  J Cancer Res Clin Oncol       Date:  2005-04-30       Impact factor: 4.553

2.  Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen.

Authors:  Y Q Wei; M J Huang; L Yang; X Zhao; L Tian; Y Lu; J M Shu; C J Lu; T Niu; B Kang; Y Q Mao; F Liu; Y J Wen; S Lei; F Luo; L Q Zhou; F Peng; Y Jiang; J Y Liu; H Zhou; Q R Wang; Q M He; F Xiao; Y Y Lou; X J Xie; Q Li; Y Wu; Z Y Ding; B Hu; M Hu; W Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

Review 3.  Recent applications of chemosensitivity tests for colorectal cancer treatment.

Authors:  Yong Sik Yoon; Jin Cheon Kim
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

4.  Antiangiogenic and antitumor activity of 6-(2-aminoethyl)amino-5-chlorouracil, a novel small-molecule inhibitor of thymidine phosphorylase, in combination with the vascular endothelial growth factor-trap.

Authors:  Haiyan Lu; Robert S Klein; Edward L Schwartz
Journal:  Clin Cancer Res       Date:  2009-08-11       Impact factor: 12.531

5.  Thymidine phosphorylase expression and stromal vascularity in ductal carcinoma in situ of the breast.

Authors:  N B Teo; B S Shoker; C Jarvis; J P Sloane; C Holcombe
Journal:  J Clin Pathol       Date:  2003-12       Impact factor: 3.411

6.  Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesis.

Authors:  S Marchetti; M Chazal; A Dubreuil; J L Fischel; M C Etienne; G Milano
Journal:  Br J Cancer       Date:  2001-08-03       Impact factor: 7.640

7.  Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma.

Authors:  R D Leek; R Landers; S B Fox; F Ng; A L Harris; C E Lewis
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

8.  4-Methylumbelliferone inhibits ovarian cancer growth by suppressing thymidine phosphorylase expression.

Authors:  Ryosuke Tamura; Yoshihito Yokoyama; Hidemi Yoshida; Tadaatsu Imaizumi; Hideki Mizunuma
Journal:  J Ovarian Res       Date:  2014-10-11       Impact factor: 4.234

9.  Clinicopathological significance of vascular endothelial growth factor, thymidine phosphorylase and microvessel density in colorectal cancer.

Authors:  Yutaka Kimura; Satoko Morohashi; Tadashi Yoshizawa; Takahiro Suzuki; Hajime Morohashi; Yoshiyuki Sakamoto; Motoi Koyama; Akihiko Murata; Hiroshi Kijima; Kenichi Hakamada
Journal:  Mol Med Rep       Date:  2015-12-17       Impact factor: 2.952

10.  A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer.

Authors:  Hephzibah Rani S Tagaram; Dhimant Desai; Guangfu Li; Dai Liu; C Bart Rountree; Kavitha Gowda; Arthur Berg; Shantu Amin; Kevin F Staveley-O'Carroll; Eric T Kimchi
Journal:  Pharmaceuticals (Basel)       Date:  2016-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.